Migraine drug up for FDA review
Biotech company says approval would result in increased workforce
By Luther Turmelle
NEW HAVEN — A biopharmaceutical company based in the city said in a regulatory filing last week that the federal Food and Drug Administration has accepted its new drug application for treatment and prevention of migraine headaches.
The Oct. 3 filing...
Read latest The Middletown Press (Middletown, CT) online.
Newspapers from USA
Newspapers in English